-
Subject Areas on Research
-
A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.
-
Analogs of tetrahydroisoquinoline natural products that inhibit cell migration and target galectin-3 outside of its carbohydrate-binding site.
-
Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure?
-
Association of Galectin-3 With Diabetes Mellitus in the Dallas Heart Study.
-
Biomarker-based risk prediction in the community.
-
Biomarkers for the Prevention of Heart Failure: Are We There Yet?
-
Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure.
-
Biomarkers, mineralocorticoid receptor antagonism, and cardiorenal remodeling.
-
Circulating galectin-3 in infections and non-infectious inflammatory diseases.
-
Effect of compressive force on unbinding specific protein-ligand complexes with force spectroscopy.
-
Effect of high-intensity interval training on muscle remodeling in rheumatoid arthritis compared to prediabetes.
-
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension.
-
Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma.
-
Galectin-3 and mineralocorticoid receptor antagonist use in patients with chronic heart failure due to left ventricular systolic dysfunction.
-
Galectin-3 directs antimicrobial guanylate binding proteins to vacuoles furnished with bacterial secretion systems.
-
Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study.
-
Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure).
-
Galectin-3 in heart failure: more answers or more questions?
-
Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community.
-
Guanylate Binding Proteins Regulate Inflammasome Activation in Response to Hyperinjected Yersinia Translocon Components.
-
Lack of galectin-1 or galectin-3 alters B cell deletion and anergy in an autoantibody transgene model.
-
Multimarker Risk Stratification in Patients With Acute Myocardial Infarction.
-
Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis.
-
Relationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTION.
-
Synephrine Hydrochloride Suppresses Esophageal Cancer Tumor Growth and Metastatic Potential through Inhibition of Galectin-3-AKT/ERK Signaling.
-
Keywords of People